LLMs in Healthcare: Benchmarks, Evaluations & Challenges (2023-2025)

The AI Doctor is In: Charting the Future of Large Language Models in Healthcare The healthcare landscape is undergoing a rapid transformation, fueled by advancements in artificial intelligence, particularly large language models (LLMs). From assisting with diagnosis to streamlining administrative tasks, LLMs are poised to revolutionize how medicine is practiced. But where are we headed? … Read more

AI-Powered Chatbot for Streamlined Clinical Referrals: Development & RCT Findings

The AI Doctor is In: How Intelligent Systems are Reshaping Healthcare’s Future The intersection of artificial intelligence and healthcare is no longer a futuristic fantasy; it’s a rapidly evolving reality. Recent research, exemplified by the development of systems like PreA – a co-designed AI consultation platform detailed in a study by the Chinese Academy of … Read more

Artificial intelligence for public health can harness data for healthier populations

The AI-Powered Future of Healthcare: Beyond Diagnosis Artificial intelligence is no longer a futuristic promise in healthcare; it’s rapidly becoming a clinical reality. Recent research, highlighted in publications like NEJM AI (Ma et al., 2024) and Nature (Kraemer et al., 2025), demonstrates AI’s growing capabilities in areas far beyond initial expectations. We’re moving past simply … Read more

TLC-2716/6665: Preclinical & Phase 1 Data on a Novel LXR Agonist for Dyslipidemia & NASH

The Future of Metabolic Disease Treatment: Beyond Statins and Towards Precision Therapies The fight against metabolic diseases like type 2 diabetes, non-alcoholic steatohepatitis (NASH), and hyperlipidemia is entering a new era. Recent research, detailed in studies examining compounds like TLC-2716 and TLC-6665, points towards a future where treatments aren’t one-size-fits-all, but tailored to individual genetic … Read more

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel

The Growing Influence of Pharma Funding in Ophthalmology: What Does the Future Hold? A recent disclosure of financial ties within the ophthalmology field – specifically, a list of researchers receiving grants and honoraria from major pharmaceutical companies like AbbVie, Bayer, and Roche – highlights a trend that’s been quietly accelerating for years. While not inherently … Read more

‘Cycling is in a downward spiral’

The Shifting Sands of Professional Cycling: Financial Strain and Rider Empowerment The recent, unexpected retirement of Simon Yates, fresh off a successful season with Visma | Lease a Bike, isn’t just a team setback – it’s a symptom of deeper issues plaguing professional cycling. Visma boss Richard Plugge’s comments at the team’s media day, highlighting … Read more

Mpox in Pregnancy: Limited Data on Clade I Risks in DR Congo

Mpox in Pregnancy: A Growing Concern, Especially in the DRC The recent global outbreaks of mpox (formerly known as monkeypox) brought the virus into sharp focus, but the situation is particularly critical in the Democratic Republic of Congo (DR Congo). Unlike the clade IIb variant that drove the 2022-2023 outbreaks, the DR Congo experiences ongoing … Read more

Multi-Omics Atlas Reveals Novel Metabolites & Pathways for Type 2 Diabetes Risk & Prediction

Unlocking the Secrets of Type 2 Diabetes: A New Era of Personalized Prevention For decades, Type 2 Diabetes (T2D) has been a growing global health crisis. But a groundbreaking study, analyzing data from over 28,000 participants across ten diverse cohorts – including the Nurses’ Health Study and the Hispanic Community Health Study – is shifting … Read more

Conflicts of Interest Disclosure: Research Funding & Affiliations

The Expanding Web of Financial Ties in Cancer Research: What It Means for the Future A recent disclosure of financial interests among leading cancer researchers, detailing relationships with a vast array of pharmaceutical and biotechnology companies, highlights a growing trend: the increasingly complex interplay between academic research, industry funding, and potential conflicts of interest. This … Read more

MK-7762: Antibacterial Activity, PK, and Efficacy in Tuberculosis Models

The Future of Tuberculosis Treatment: Beyond the Bench and Into the Body Tuberculosis (TB), a disease once thought to be fading into history, is staging a concerning comeback. Drug resistance is escalating, and existing treatments are lengthy and often debilitating. However, a wave of cutting-edge research, detailed in recent studies like the one exploring MK-7762, … Read more